These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 17308142

  • 1. Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age.
    Pasquali R, Gambineri A.
    Ann N Y Acad Sci; 2006 Dec; 1092():158-74. PubMed ID: 17308142
    [Abstract] [Full Text] [Related]

  • 2. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN, Merchant R.
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [Abstract] [Full Text] [Related]

  • 3. The impact of obesity on reproduction in women with polycystic ovary syndrome.
    Pasquali R, Gambineri A, Pagotto U.
    BJOG; 2006 Oct; 113(10):1148-59. PubMed ID: 16827825
    [Abstract] [Full Text] [Related]

  • 4. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B, Gambineri A, Pasquali R.
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [Abstract] [Full Text] [Related]

  • 5. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
    Brzozowska MM, Ostapowicz G, Weltman MD.
    J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
    [Abstract] [Full Text] [Related]

  • 6. Obesity and the polycystic ovary syndrome.
    Martínez-Bermejo E, Luque-Ramírez M, Escobar-Morreale HF.
    Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
    [Abstract] [Full Text] [Related]

  • 7. Polycystic ovary syndrome in men: Stein-Leventhal syndrome revisited.
    Kurzrock R, Cohen PR.
    Med Hypotheses; 2007 Sep; 68(3):480-3. PubMed ID: 17134841
    [Abstract] [Full Text] [Related]

  • 8. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM, Wass JA, McCarthy MI, Franks S.
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [Abstract] [Full Text] [Related]

  • 9. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F, Vuolo L, Palomba S, Lombardi G, Colao A.
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [Abstract] [Full Text] [Related]

  • 10. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC, Galluzzo A, Finocchiaro S, Criscimanna A, Giordano C.
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [Abstract] [Full Text] [Related]

  • 11. Development of polycystic ovary syndrome: involvement of genetic and environmental factors.
    Franks S, McCarthy MI, Hardy K.
    Int J Androl; 2006 Feb; 29(1):278-85; discussion 286-90. PubMed ID: 16390494
    [Abstract] [Full Text] [Related]

  • 12. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
    Nardo LG, Patchava S, Laing I.
    Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
    [Abstract] [Full Text] [Related]

  • 13. Polycystic ovary syndrome in adolescents.
    Franks S.
    Int J Obes (Lond); 2008 Jul; 32(7):1035-41. PubMed ID: 18458678
    [Abstract] [Full Text] [Related]

  • 14. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
    Moran L, Teede H.
    Hum Reprod Update; 2009 Jul; 15(4):477-88. PubMed ID: 19279045
    [Abstract] [Full Text] [Related]

  • 15. Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia.
    Hahn S, Tan S, Elsenbruch S, Quadbeck B, Herrmann BL, Mann K, Janssen OE.
    Horm Metab Res; 2005 Jul; 37(7):438-44. PubMed ID: 16034717
    [Abstract] [Full Text] [Related]

  • 16. Changes in the PCOS phenotype with age.
    Hsu MI.
    Steroids; 2013 Aug; 78(8):761-6. PubMed ID: 23624031
    [Abstract] [Full Text] [Related]

  • 17. Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome.
    Diamanti-Kandarakis E, Christakou C, Kandarakis H.
    Minerva Endocrinol; 2007 Mar; 32(1):35-47. PubMed ID: 17353865
    [Abstract] [Full Text] [Related]

  • 18. Association between the polycystic ovary syndrome and the metabolic syndrome in Puerto Rico.
    Rabelo Acevedo M, Vick MR.
    P R Health Sci J; 2005 Sep; 24(3):203-6. PubMed ID: 16329683
    [Abstract] [Full Text] [Related]

  • 19. The metabolic syndrome in young Korean women with polycystic ovary syndrome.
    Park HR, Choi Y, Lee HJ, Oh JY, Hong YS, Sung YA.
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S243-6. PubMed ID: 17610984
    [Abstract] [Full Text] [Related]

  • 20. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
    Otto-Buczkowska E, Jarosz-Chobot P, Deja G.
    Przegl Lek; 2006 Sep; 63(4):234-8. PubMed ID: 17080748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.